TENDER RESULTS. Notification of Product Changes (NOPC) forms and Pharmacodes. 30 May 2014

Similar documents
Notification of Product Changes (NOPC) forms, Containered Trade Product Pack (CTPP) codes and Pharmacodes

TENDER RESULTS. Notification of Product Changes (NOPC) forms and Pharmacodes. 19 December 2014

Notification of Product Changes (NOPC) forms, Containered Trade Product Pack (CTPP) codes and Pharmacodes

TENDER RESULTS. Notification of Product Changes (NOPC) forms and Pharmacodes. 31 October 2014

TENDER RESULTS. Notification of Product Changes (NOPC) forms and Pharmacodes. 30 April 2014

TENDER RESULTS. Notification of Product Changes (NOPC) forms and Pharmacodes. 28 February 2014

Notification of Product Changes (NOPC) forms, Containered Trade Product Pack (CTPP) codes and Pharmacodes

TENDER RESULTS. Notification of Product Changes (NOPC) forms and Pharmacodes

Notification of Product Changes (NOPC) forms, Containered Trade Product Pack (CTPP) codes and Pharmacodes

Notification of Product Changes (NOPC) forms, Containered Trade Product Pack (CTPP) codes and Pharmacodes

2007/08 Tender. Current Subsidy and price. Bendrofluazide Tab 5 mg; 500 tablets, bottle $21.50 $11.75 Arrow-Bendrofluazide (Arrow)

Your DISPENSARY Tips as at 26 November 2015

Your DISPENSARY Tips as at 11 March 2016

Release of the 2013/14 Invitation to Tender

Price Changes advised by Pharmac As at 12 June 2015

Section H. Pharmaceuticals. New Zealand Pharmaceutical Schedule. Effective 1 July for Hospital. The Hospital Medicines List (HML)

Release of the 2017/18 Invitation to Tender

Pharmaceutical Management Agency. Section H Update. for Hospital. Pharmaceuticals. Effective 1 August 2018

Approval of proposals for various pharmaceuticals

Section H. Pharmaceuticals. New Zealand. Pharmaceutical Schedule. Effective 1 July for Hospital. The Hospital Medicines List (HML)

Section H. Pharmaceuticals. New Zealand. Pharmaceutical Schedule. Effective 1 July for Hospital. The Hospital Medicines List (HML)

July 2017 Section H of the Pharmaceutical Schedule Update

Price Changes advised by Pharmac As at 02 July 2015

Pharmaceutical Management Agency. Section H Update. for Hospital. Pharmaceuticals. Effective 1 December 2018

New Zealand Pharmaceutical Schedule

Proposals regarding the Cholesterol Lowering Pharmaceuticals Atorvastatin and Ezetimibe

REQUEST FOR PROPOSALS SUPPLY OF NICOTINE REPLACEMENT THERAPY

Approval of Multiple Diabetes Management Products and Mesalazine proposals

To: Medical Groups, DHB Hospital Pharmacies and Interested Parties

(price) Underlined indicates tender winning product now available at new subsidy $5.62 $4.89. $2.35 (Manuf price $5.26) $2.59

Proposal relating to the funding of TNF inhibitors (Humira and Enbrel) and gabapentin (Neurontin)

Mental Health Subcommittee of PTAC meeting held 21 June (minutes for web publishing)

Section H. Pharmaceuticals. Pharmaceutical Schedule. Effective 1 July for Hospital. Update effective 1 November 2014

Inhalers containing CFCs. CFC-free inhalers

Proposal on subsidy changes for some respiratory inhalation products and access restrictions to combination inhalers.

Decision relating to the funding of TNF inhibitors (Humira and Enbrel) and gabapentin (Neurontin)

REQUEST FOR PROPOSALS SUPPLY OF NICOTINE REPLACEMENT THERAPY

New Zealand Pharmaceutical Schedule

New Zealand Pharmaceutical Schedule

New Zealand Pharmaceutical Schedule

New Zealand Pharmaceutical Schedule

Supply should only occur if requesting signature is on approved list held by the issuing pharmacy

Release of the 2014/15 Invitation to Tender

New Zealand Pharmaceutical Schedule

New Zealand Pharmaceutical Schedule

New Zealand Pharmaceutical Schedule

New Zealand Pharmaceutical Schedule

for Hospital Pharmaceuticals

New Zealand Pharmaceutical Schedule

Update New Zealand Pharmaceutical Schedule Effective 1 September 2017

New Zealand Pharmaceutical Schedule

New Zealand Pharmaceutical Schedule

Update New Zealand Pharmaceutical Schedule Effective 1 September 2016

Pharmacy Medical Necessity Guidelines: Antipsychotic Medications

Update New Zealand Pharmaceutical Schedule Effective 1 February 2018 Cumulative for January and February 2018

Section H. Pharmaceuticals. New Zealand. Pharmaceutical Schedule. Effective 1 July for Hospital. The Hospital Medicines List (HML)

Seasonal Flu Vaccine Offers

Update New Zealand Pharmaceutical Schedule Effective 1 May 2018

Update New Zealand Pharmaceutical Schedule Effective 1 May 2016

DATE OF PRE-BID CONFERENCE: DEADLINE OF SUBMISSION OF BIDS: OPENING OF BIDS:

Update New Zealand Pharmaceutical Schedule Effective 1 March 2017 Cumulative for January, February and March 2017

New Zealand Pharmaceutical Schedule

Update New Zealand Pharmaceutical Schedule Effective 1 December 2016 Cumulative for September, October, November and December 2016

Approximate Cost for Patients

PHARMACY SERVICE ARRANGEMENTS FOR THE SUPPLY OF PALLIATIVE CARE SYRINGES AND MEDICINES FOR COMMUNITY PATIENTS

Update New Zealand Pharmaceutical Schedule

Influenza Immunization Drug Cards

Advance Notification of Amendments to the December 2018 Drug Tariff

UPLB-S , SUPPLY AND DELIVERY OF DRUGS AND MEDICINES TECHNICAL SPECIFICATION FOR THE PUBLIC BIDDING OF: OPENING OF BIDS:

Mediscor Medicines Review 2011

New Zealand Pharmaceutical Schedule

New Zealand Pharmaceutical Schedule

$55. today. Register. New Zealand Pharmaceutical Schedule. Effective 1 August www. schedule. co.nz. Sign up. Only

NHS Pharmaceutical Quality Assurance Service Safe Medication Bulletin

February Introducing PHARMAC 2. Part I General Rules 5

Section H. Pharmaceuticals. New Zealand. Pharmaceutical Schedule. Effective 1 July for Hospital. Update effective 1 October 2015

Price List Effective 1June 2011.

Seasonal Flu Vaccine Offers 2015/16

Medicines Formulary BNF Section 4 Central Nervous System

Pharmacy Benefit Management (PBM) Program FORMULARY/PRODUCT RESTRICTIONS

Update. New Zealand Pharmaceutical Schedule. Effective 1 November Cumulative for September, October and November 2018

New Zealand Pharmaceutical Schedule

Update New Zealand Pharmaceutical Schedule

Piles of pills: Prescribing appropriate quantities of medicines. 10 BPJ Issue 69

Update New Zealand Pharmaceutical Schedule Effective 1 April 2016 Cumulative for January, February, March and April 2016

DT Description Price Category Price change

Update New Zealand Pharmaceutical Schedule Effective 1 January 2019

New Zealand Pharmaceutical Schedule

Updates to the Alberta Drug Benefit List. Effective September 1, 2018

Seasonal Flu Vaccine Offers

Update New Zealand Pharmaceutical Schedule Effective 1 January 2018

PEI Drug Programs. Issue October, 2006

New Zealand Pharmaceutical Schedule

Part 2: Pain and Symptom Management Nausea and Vomiting

Hospital Pharmaceuticals Review PTAC, Hospital Pharmaceuticals Subcommittee & Respiratory Subcommittee minutes for web publishing

Pharmacy Medical Necessity Guidelines: Atypical Antipsychotic Medications. Effective: December 12, 2017

Update New Zealand Pharmaceutical Schedule Effective 1 July 2018 Cumulative for May, June and July 2018

DT Description Price Category Price change Percentage BNF 1.2 Mebeverine 135mg tablets (100) 759 M %

New Zealand Pharmaceutical Schedule

Transcription:

30 May 2014 TENDER RESULTS PHARMAC has resolved to award tenders for Sole Subsidised Supply Status and Hospital Supply Status for some products included in the 2012/13 Invitation to Tender, dated 31 October 2012 and 2013/14 Invitation to Tender, dated 07 November 2013. Some of the pharmaceuticals that will be delisted when the period of Sole Subsidised Supply/Hospital Supply Status commences may be subject to existing listing contracts with PHARMAC. Suppliers of pharmaceuticals that are subject to such contracts should continue to supply their pharmaceuticals under those contracts. PHARMAC will continue to subsidise those pharmaceuticals accordingly until such time as those pharmaceuticals are delisted. Notification of Product Changes (NOPC) forms and Pharmacodes Please note that for any changes ( change, pack size change, new listing etc) to be effective in the Pharmaceutical Schedule (including Section H), suppliers are required to notify any changes to PHARMAC and the Pharmacy Guild of New Zealand by 4pm on the 12 th of the month prior to the date of subsidy change. More information and NOPC forms can be found on our website http://www.pharmac.health.nz/medicines/how-medicines-arefunded/new-funding-applications/pharmaceutical-product-specifications-the-change-process Where a product does not have a current Pharmacode, suppliers are required to ensure that a Pharmacode has been obtained from the Pharmacy Guild of New Zealand before the 12 th of the month prior to the date of listing. PHARMAC cannot list a product (and pharmacies cannot claim) without the correct Pharmacode. A697939 Page 1 of 17

2012/13 Tender Sole Subsidised Supply Status or Hospital Supply Status applies until 30 June 2016 Community pharmaceutical tenders Section B of the Pharmaceutical Schedule 1. Tenders awarded to currently listed pharmaceuticals where no other brand is listed. The decisions were as follows: Chemical name subsidy and () New subsidy and Date of subsidy change Sole Subsidised Supply date Tranexamic acid tab 500 mg; 100, bottle pack $32.92 $23.00 Cyklokapron (Pfizer) 1 August 2014 1 November 2014 Hospital pharmaceutical tenders Section H of the Pharmaceutical Schedule 2. Tenders awarded to listed pharmaceuticals where only the current brand is listed. The decisions were as follows: Chemical Name pack New pack Hospital Supply DV Limit Date of change Hospital Supply Status date Tranexamic acid tab 500 mg; 100, bottle pack $32.92 $23.00 Cyklokapron (Pfizer) 1% 1 August 2014 1 October 2014 A697939 Page 2 of 17

2013/14 Tender Sole Subsidised Supply Status or Hospital Supply Status applies until 30 June 2017 Community pharmaceutical tenders Section B of the Pharmaceutical Schedule 3. Tenders awarded to pharmaceuticals where at least one other brand or pack size is listed. The decisions were as follows: Chemical Name subsidy and () New subsidy and Date of listing/subsidy Date of reference pricing of other listed brands Sole Subsidised Supply date (and delisting of other listed brands) affected by reference pricing and delisting Amitriptyline 1 tab 25 mg; 100, blister pack $1.85 $1.68 Arrow-Amitriptyline 1 October 2014 1 December 2014 1 March 2015 Amitrip Amitriptyline 1 tab 50 mg; 100, blister pack $3.60 $2.82 Arrow-Amitriptyline 1 October 2014 1 December 2014 1 March 2015 Amitrip Amorolfine nail soln 5%; 5 ml OP, bottle pack $37.86 ($61.87) $19.95 MycoNail (AFT) 1 November 2014 1 January 2015 1 April 2015 Loceryl (Healthcare Logistics) Imiquimod crm 5%, 250 mg sachet; 12 sachets $62.00 $17.98 Apo-Imiquimod Cream 5% 1 December 2014 1 February 2015 1 May 2015 Aldara (Valeant) Octreotide inj 50 mcg per ml, 1 ml vial; 5 vials $19.24 $13.50 DBL Octreotide MaxRx (Max Health) Octreotide inj 100 mcg per ml, 1 ml vial; 5 vials $36.38 $22.40 DBL Octreotide MaxRx (Max Health) Octreotide inj 500 mcg per ml, 1 ml vial; 5 vials $131.25 $89.40 DBL Octreotide MaxRx (Max Health) A697939590547 - qa25123 Page 3 of 17

Chemical Name subsidy and () New subsidy and Date of listing/subsidy Date of reference pricing of other listed brands Sole Subsidised Supply date (and delisting of other listed brands) affected by reference pricing and delisting Olanzine-D + Olanzapine 2 tab orodispersible 5 mg; 28, blister pack $6.36 $1.75 Zypine ODT Dr Reddy s Olanzapine Zyprexa Zydis (Eli Lilly) Olanzine-D + Olanzapine 2 tab orodispersible 10 mg; 28, blister pack $8.76 $3.05 Zypine ODT Dr Reddy s Olanzapine Zyprexa Zydis (Eli Lilly) + Olanzapine 2 tab 2.5 mg; 28, blister pack $2.00 $0.75 Zypine Dr Reddy s Olanzapine Zyprexa (Eli Lilly) Olanzine + Olanzapine 2 tab 5 mg; 28, blister pack $3.85 $1.65 Zypine Dr Reddy s Olanzapine Zyprexa (Eli Lilly) Olanzine + Olanzapine 2 tab 10 mg; 28, blister pack $6.35 $2.55 Zypine Dr Reddy s Olanzapine Zyprexa (Eli Lilly) A697939590547 - qa25123 Page 4 of 17

Chemical Name subsidy and () New subsidy and Date of listing/subsidy Date of reference pricing of other listed brands Sole Subsidised Supply date (and delisting of other listed brands) affected by reference pricing and delisting Paracetamol with codeine tab paracetamol 500 mg with codeine phosphate 8 mg; 1,000, blister pack $2.70 per 100 s $21.06 per 1,000 s Paracetamol + Codeine (Relieve) 1 October 2014 1 December 2014 1 March 2015 Paracetamol + Codeine (Relieve) - 100 packsize Dr Reddy s Quetiapine + Quetiapine 2 tab 25 mg; 90, blister pack $10.50 per 90 s $2.10 per 90 s Quetapel Seroquel Dr Reddy s Quetiapine + Quetiapine 2 tab 100 mg; 90, blister pack $21.00 per 90 s $4.20 per 90 s Quetapel Seroquel Dr Reddy s Quetiapine + Quetiapine 2 tab 200 mg; 90, blister pack $36.00 per 90 s $7.20 per 90 s Quetapel Seroquel Dr Reddy s Quetiapine + Quetiapine 2 tab 300 mg; 90, blister pack $60.00 per 90 s $12.00 per 90 s Quetapel Seroquel + 2 oral liq1 mg per ml; 30 ml, bottle pack $18.35 $9.75 Risperon A697939590547 - qa25123 Page 5 of 17

Chemical Name subsidy and () New subsidy and Date of listing/subsidy Date of reference pricing of other listed brands Sole Subsidised Supply date (and delisting of other listed brands) affected by reference pricing and delisting + 3 tab 0.5 mg; 60, blister pack $3.51 per 60 $1.90 per 60 1 October 2014 1 February 2015 1 May 2015 + 3 tab 1 mg; 60, blister pack $6.00 per 60 $2.10 per 60 1 October 2014 1 February 2015 1 May 2015 + 3 tab 2 mg; 60, blister pack $11.00 per 60 $2.34 per 60 1 October 2014 1 February 2015 1 May 2015 A697939590547 - qa25123 Page 6 of 17

Chemical Name subsidy and () New subsidy and Date of listing/subsidy Date of reference pricing of other listed brands Sole Subsidised Supply date (and delisting of other listed brands) affected by reference pricing and delisting + 3 tab 3 mg; 60, blister pack $15.00 per 60 $2.55 per 60 1 October 2014 1 February 2015 1 May 2015 + 3 tab 4 mg; 60, blister pack $20.00 per 60 $3.50 per 60 1 October 2014 1 February 2015 1 May 2015 + We will be providing more information about the antipsychotic changes for clinicians, consumers, pharmacies and caregivers over the coming months 1. A Brand Switch Fee of $4.33 is payable for this product from 1 March 2015 until 1 June 2015 2. A Brand Switch Fee of $4.33 is payable for this product from 1 December 2014 until 1 March 2015 3. A Brand Switch Fee of $4.33 is payable for this product from 1 May 2015 until 1 August 2015 4. Tenders awarded to currently listed pharmaceuticals where no other brand is listed. The decisions were as follows: Chemical name subsidy and () New subsidy and Date of subsidy change Sole Subsidised Supply date Amitriptyline tab 10 mg; 100, blister pack $3.32 $1.68 Arrow-Amitriptyline A697939590547 - qa25123 Page 7 of 17

Chemical name subsidy and () New subsidy and Date of subsidy change Sole Subsidised Supply date Calcium carbonate tab 1.25 g (500 mg elemental); 250, bottle pack $6.38 $5.38 Arrow-Calcium Fluconazole cap 50 mg; 28 capsule, blister pack $4.77 $3.49 Ozole 1 September 2014 1 December 2014 Fluconazole cap 150 mg; 1 capsule, blister pack $0.91 $0.71 Ozole 1 September 2014 1 December 2014 Fluconazole cap 200 mg; 28 capsule, blister pack $13.34 $9.69 Ozole 1 September 2014 1 December 2014 Ipratropium bromide aqueous nasal spray, 0.03%; 15 ml, vial $4.03 $3.95 Univent (Rex Medical) 1 November 2014 1 February 2015 Lidocaine [lignocaine] oral (viscous) soln 2%; 200 ml, bottle pack $55.00 $55.00 Xylocaine Viscous Pethidine inj 50 mg per ml, 1 ml; 5 ampoules $5.51 $5.51 DBL Pethidine Hydrochloride Pethidine inj 50 mg per ml, 2 ml; 5 ampoules $5.83 $5.83 DBL Pethidine Hydrochloride Simvastatin tab 10 mg; 90, blister pack $1.40 $0.95 Arrow-Simva 10mg Simvastatin tab 20 mg; 90, blister pack $1.95 $1.61 Arrow-Simva 20mg Simvastatin tab 40 mg; 90, blister pack $3.18 $2.83 Arrow-Simva 40mg Simvastatin tab 80 mg; 90, blister pack $9.31 $7.91 Arrow-Simva 80mg A697939590547 - qa25123 Page 8 of 17

5. Tenders awarded to pharmaceuticals where no brand is listed. The decisions were as follows: Chemical Name Pack Listing date Sole Subsidised Supply date Granisetron * tab 1 mg; 50, blister pack $5.98 Granirex (Rex Medical) 1 November 2014 1 February 2015 *Stat dispensing will apply to this product A697939590547 - qa25123 Page 9 of 17

Hospital pharmaceutical tenders Section H of the Pharmaceutical Schedule 6. Tenders awarded to pharmaceuticals where at least one other brand or pack size is listed. The decisions were as follows: Chemical Name pack New pack Hospital Supply DV Limit Date of listing/ Hospital Supply Status date (and delisting of other listed brands) to be delisted Amitriptyline tab 25 mg; 100, blister pack $1.85 $1.68 Arrow-Amitriptyline 1% 1 October 2014 1 December 2014 Amitrip Amitriptyline tab 50 mg; 100, blister pack $3.60 $2.82 Arrow-Amitriptyline 1% 1 October 2014 1 December 2014 Amitrip *Amorolfine nail soln 5%; 5 ml, bottle pack $37.86 $19.95 MycoNail (AFT) 1% 1 November 2014 1 January 2015 Loceryl (Healthcare Logistics) Imiquimod crm 5%, 250 mg sachet; 12 sachets $62.00 $17.98 Apo-Imiquimod Cream 5% 1% 1 December 2014 1 February 2015 Aldara (Valeant) Octreotide inj 50 mcg per ml, 1 ml vial; 5 vials $19.24 $13.50 DBL Octreotide MaxRx (Max Health) Octreotide inj 100 mcg per ml, 1 ml vial; 5 vials $36.38 $22.40 DBL Octreotide MaxRx (Max Health) Octreotide inj 500 mcg per ml, 1 ml vial; 5 vials $131.25 $89.40 DBL Octreotide MaxRx (Max Health) + Olanzapine tab orodispersible 5 mg; 28, blister pack $6.36 $1.75 Zypine ODT Olanzine-D + Olanzapine tab orodispersible 10 mg; 28, blister pack $8.76 $3.05 Zypine ODT Olanzine-D + Olanzapine tab 2.5 mg; 28, blister pack $2.00 $0.75 Zypine Olanzine + Olanzapine tab 5 mg; 28, blister pack $3.85 $1.65 Zypine Olanzine + Olanzapine tab 10 mg; 28, blister pack $6.35 $2.55 Zypine Olanzine A697939590547 - qa25123 Page 10 of 17

Chemical Name pack New pack Hospital Supply DV Limit Date of listing/ Hospital Supply Status date (and delisting of other listed brands) to be delisted Paclitaxel 1 inj 6 mg per ml, 16.7 ml vial; 1 vial $91.67 $19.02 Paclitaxel Ebewe (Sandoz) Paclitaxel Actavis Paclitaxel 1 inj 6 mg per ml, 25 ml vial; 1 vial $137.50 $26.69 Paclitaxel Ebewe (Sandoz) Paclitaxel Actavis Anzatax Paclitaxel 1 inj 6 mg per ml, 50 ml via; 1 vial $275.00 $36.53 Paclitaxel Ebewe (Sandoz) Paclitaxel Actavis Anzatax Dr Reddy s Quetiapine + Quetiapine tab 25 mg; 90, blister pack $10.50 per 90 s $2.10 per 90 s Quetapel Seroquel Dr Reddy s Quetiapine + Quetiapine tab 100 mg; 90, blister pack $21.00 per 90 s $4.20 per 90 s Quetapel Seroquel Dr Reddy s Quetiapine + Quetiapine tab 200 mg; 90, blister pack $36.00 per 90 s $7.20 per 90 s Quetapel Seroquel A697939590547 - qa25123 Page 11 of 17

Chemical Name pack New pack Hospital Supply DV Limit Date of listing/ Hospital Supply Status date (and delisting of other listed brands) to be delisted + Quetiapine tab 300 mg; 90, blister pack $60.00 per 90 s $12.00 per 90 s Quetapel Dr Reddy s Quetiapine Seroquel + oral liq1 mg per ml; 30 ml, bottle pack $18.35 $9.75 Risperon + tab 0.5 mg; 60, blister pack $3.51 per 60 $1.90 per 60 1% 1 October 2014 1 February 2015 + tab 1 mg; 60, blister pack $6.00 per 60 $2.10 per 60 1% 1 October 2014 1 February 2015 A697939590547 - qa25123 Page 12 of 17

Chemical Name pack New pack Hospital Supply DV Limit Date of listing/ Hospital Supply Status date (and delisting of other listed brands) to be delisted + tab 2 mg; 60, blister pack $11.00 per 60 $2.34 per 60 1% 1 October 2014 1 February 2015 + tab 3 mg; 60, blister pack $15.00 per 60 $2.55 per 60 1% 1 October 2014 1 February 2015 + tab 4 mg; 60, blister pack $20.00 per 60 $3.50 per 60 1% 1 October 2014 1 February 2015 *Restrictions which currently apply for this product will be removed from 1 Novemeber 2014 + We will be providing more information about the antipsychotic changes for clinicians, consumers, pharmacies and caregivers over the coming months 1. The and subsidy of paclitaxel (PCT Retail Pharmacy Specialist) in Section B of the Pharmaceutical Schedule will also be amended to the above s from 1 July 2014. The subsidy for paclitaxel inj 1 mg for ECP in Section B of the Pharmaceutical Schedule will change from $1.02 per 1 mg to $0.17 per 1 mg from 1 July 2014 A697939590547 - qa25123 Page 13 of 17

7. Tenders awarded to listed pharmaceuticals where only the current brand is listed. The decisions were as follows: Chemical Name pack New pack Hospital Supply DV Limit Date of change Hospital Supply Status date Amitriptyline tab 10 mg; 100, blister pack $3.32 $1.68 Arrow-Amitriptyline Calcium carbonate tab 1.25 g (500 mg elemental); 250, bottle pack $6.38 $5.38 Arrow-Calcium Fluconazole cap 50 mg; 28 capsule, blister pack $4.77 $3.49 Ozole 1% 1 September 2014 1 November 2014 Fluconazole cap 150 mg; 1 capsule, blister pack $0.91 $0.71 Ozole 1% 1 September 2014 1 November 2014 Fluconazole cap 200 mg; 28 capsule, blister pack $13.34 $9.69 Ozole 1% 1 September 2014 1 November 2014 Lidocaine [lignocaine] oral (viscous) soln 2%; 200 ml, bottle pack $55.00 $55.00 Xylocaine Viscous Paclitaxel 1 inj 6 mg per ml, 5 ml vial; 5 vials $137.50 $45.00 Paclitaxel Ebewe (Sandoz) Paclitaxel 1 inj 6 mg per ml, 100 ml vial; 1 vial $550.00 $73.06 Paclitaxel Ebewe (Sandoz) Pethidine inj 50 mg per ml, 1 ml; 5 ampoules $5.51 $5.51 DBL Pethidine Hydrochloride Pethidine inj 50 mg per ml, 2 ml; 5 ampoules $5.83 $5.83 DBL Pethidine Hydrochloride Simvastatin tab 10 mg; 90, blister pack $1.40 $0.95 Arrow-Simva 10mg Simvastatin tab 20 mg; 90, blister pack $1.95 $1.61 Arrow-Simva 20mg Simvastatin tab 40 mg; 90, blister pack $3.18 $2.83 Arrow-Simva 40mg A697939590547 - qa25123 Page 14 of 17

Simvastatin tab 80 mg; 90, blister pack $9.31 $7.91 Arrow-Simva 80mg 1. The and subsidy of paclitaxel (PCT Retail Pharmacy Specialist) in Section B of the Pharmaceutical Schedule will also be amended to the above s from 1 July 2014. The subsidy for paclitaxelinj 1 mg for ECP in Section B of the Pharmaceutical Schedule will change from $1.02 per 1 mg to $0.17 per 1 mg from 1 July 2014 8. Tenders awarded to pharmaceuticals where no brand is listed. The decisions were as follows: Chemical Name Pack Hospital Supply DV Limit Listing date Hospital Supply Status date Alfentanil inj 0.5 mg per ml, 2 ml ampoule; 10 ampoules $39.07 Hameln (Max Health) 1% 1 November 2014 1 January 2015 Atovaquone with proguanil tab 62.5 mg with proguanil 25 mg; 12 $25.00 Malarone Junior (GSK) 1% 1 September 2014 1 November 2014 Atovaquone with proguanil tab 250 mg with proguanil 100 mg; 12 $64.00 Malarone (GSK) 1% 1 September 2014 1 November 2014 Granisetron tab 1 mg; 50, blister pack $5.98 Granirex (Rex Medical) 1% 1 November 2014 1 January 2015 Ipratropium bromide aqueous nasal spray, 0.03%; 15 ml, vial $3.95 Univent (Rex Medical) 1% 1 November 2014 1 January 2015 Ketamine inj 1 mg per ml, 100 ml bag $27.00 Ketamine inj 4 mg per ml, 50 ml syringe $25.00 Ketamine inj 10 mg per ml, 10 ml syringe $14.00 Biomed (Biomed) Biomed (Biomed) Biomed (Biomed) A697939590547 - qa25123 Page 15 of 17

Tender declines - Products where no tender is to be awarded for Sole Subsidised Supply Status or Hospital Supply Status PHARMAC has resolved not to award tenders for Sole Subsidised Supply Status or Hospital Supply Status for the following products listed in the 2012/13 Invitation to Tender, dated 31 October 2012 and 2013/14 Invitation to Tender, dated 07 November 2013: 2013/14 Invitation to Tender Chemical Name Line Item Chemical Name Line Item Isosorbide mononitrate Tab long-acting 60 mg Fentanyl inj 20 mcg per ml, 50 ml prefilled syringe Bupivacaine with fentanyl Bupivacaine with fentanyl Bupivacaine with fentanyl Bupivacaine with fentanyl Bupivacaine with fentanyl Bupivacaine with fentanyl Bupivacaine with fentanyl Calcium carbonate Fentanyl Fentanyl Inj 0.625 mg with fentanyl 2 mcg per ml, 100 ml bag Inj 1.25mg with 2 mcg fentanyl per ml, 15 ml syringe Inj 1.25mg with 2 mcg fentanyl per ml, 20 ml syringe Inj 1.25 mg with fentanyl 2 mcg per ml, 50 ml syringe Inj 1.25 mg with fentanyl 2 mcg per ml, 100 ml syringe Inj 1.25mg with 2 mcg fentanyl per ml, 100 ml bag Inj 1.25mg with 2 mcg fentanyl per ml, 200 ml bag tab eff 0.875-1.75 g (0.5 g - 1 g elemental) inj 10 mcg per ml, 10 ml syringe inj 10 mcg per ml, 50 ml prefilled syringe Fentanyl Fentanyl Fentanyl Granisetron Hyoscine N-butylbromide Lidocaine [lignocaine] Octreotide (somatostatin analogue) Octreotide (somatostatin analogue) Octreotide (somatostatin analogue) Quetiapine inj 10 mcg per ml, 50 ml premixed bag inj 10 mcg per ml, 100 ml premixed bag inj 20 mcg per ml, 100 ml bag Tab 2 mg Inj 20 mg, 1 ml Oral [viscous] soln 4% LAR inj 10 mg LAR inj 20 mg LAR inj 30 mg Tab 12.5 mg PHARMAC has resolved not to award tenders for Hospital Supply Status for the following products listed in the 2013/14 Invitation to Tender, dated 07 November 2013: Chemical Name Paracetamol with codeine Line Item tab paracetamol 500 mg with codeine phosphate 8 mg A697939590547 - qa25123 Page 16 of 17

For products included in the 2011/12 Invitation to Tender, 2012/13 or the 2013/14 Invitation to Tender where no announcement has yet been made, either a decision is still pending or is provisional, subject to the product gaining market approval and being available to supply, and subject to PHARMAC Board (or its delegate) approval. We will keep you informed of any updates regarding such tender products as decisions are made. If you have any queries regarding this notification please contact PHARMAC on 0800 66 00 50. A697939590547 - qa25123 Page 17 of 17